scholarly journals A case report: a heterozygous deletion (2791_2805 del) in exon 18 of the filamin C gene causing filamin C-related myofibrillar myopathies in a Chinese family

BMC Neurology ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Jing Miao ◽  
Fei-fei Su ◽  
Xue-mei Liu ◽  
Xiao-jing Wei ◽  
Yun Yuan ◽  
...  
2021 ◽  
Vol 22 ◽  
Author(s):  
Sara Jasmin Hooshmand ◽  
Raghav Govindarajan ◽  
Brian P. Bostick

2021 ◽  
Vol 9 (18) ◽  
pp. 4721-4727
Author(s):  
Hui-Fang Liu ◽  
Qing Li ◽  
You-Qun Peng

2021 ◽  
Vol 12 ◽  
Author(s):  
Qiuming Hu ◽  
Huazhong Ma ◽  
Jiawei Shen ◽  
Zongming Zhuang ◽  
Jianqiang Li ◽  
...  

Background: Waardenburg Syndrome Type 1 (WS1) is a rare hereditary disease, which is usually caused by the mutations of PAX3 (paired box 3). Here, we reported a pedigree with WS1, which was caused by a novel mutation in PAX3.Case Report: In this present report, a 10-year-old boy and his twin sister from a Han Chinese family presented with iris pigmentary abnormality, synophrys, and broad and high nasal root. Their father presented premature whitening of the hair, but no iris pigmentary abnormality. Their aunts presented the same clinical characteristics with the twins and premature graying of hair. However, none of the patients reported hearing loss. The clinical diagnosis of the four patients from this pedigree was WS1. The whole exome sequencing (WES) revealed a novel mutation (c.959-5T>G) in the PAX3 gene, which could be responsible for the observed pathogenic of WS1 in this pedigree. The genetic test confirmed the diagnosis of WS1 in the four patients from the studied pedigree.Conclusion: This present study demonstrated that genetic test based on WES, an effective alternative to regular clinical examinations, helps diagnose WS1. The newly identified PAX3 gene mutation can expand the understanding of WS1.


2020 ◽  
Vol 40 (05) ◽  
pp. 650-654
Author(s):  
Yu Wang ◽  
Haiyue Zhang ◽  
Siqi Liu ◽  
Jiajia Ye

Abstract Objective To study the molecular basis of human coagulation factor XII (FXII) deficiency in a Chinese family. Methods Routine blood coagulation indexes were detected by a one-stage clotting method, whereas FXII antigen was detected by enzyme linked immunosorbent assay. DNA sequencing was applied to find mutations in the F12 gene. Bioinformatics and conservative analyses were performed to analyze possible effects of the mutation. Results The proband had significantly prolonged activated partial thromboplastin time (141.9 seconds), and her FXII clotting activity was decreased to 5%. Genetic analysis revealed that the propositus carried a heterozygous missense mutation c.797G > A in exon 8 resulting in Cys247Tyr and deletion mutation c.809_811delACA in exon 9 resulting in 252delAsn. Bioinformatics results indicated that the mutation had affected the function of the protein. Conclusion The c.797G > A heterozygous missense variation and the c.809_811delACA heterozygous deletion variation are associated with decreased FXII levels in this family, of which c.797G > A is first reported in the world.


Sign in / Sign up

Export Citation Format

Share Document